INTRODUCTION: Sepsis-induced acute kidney injury (AKI) remains a major challenge in intensive care, contributing significantly to morbidity and mortality. Tibolone, known for its neuroprotective and hormonal properties, has not been explored for its potential in AKI management. This study investigates the protective effects of Tibolone and its underlying mechanisms involving Sirtuin-1 (SIRT1) and Yes-Associated Protein (YAP) in a rat sepsis model. MATERIALS AND METHODS: Thirty-six female Wistar albino rats underwent cecal ligation and puncture (CLP) to induce sepsis. They were randomly assigned to control, CLP+Saline, and CLP+Tibolone groups. Tibolone was administered intraperitoneally. Biomarkers, including Sirtuin (SIRT1), Yes-associated protein (YAP), Tumor necrosis factor (TNF-α), High mobility group box 1 (HMGB1), malondialdehyde (MDA), creatinine, and urea, were assessed. Histopathological examination evaluated renal damage. RESULTS: Tibolone administration significantly reduced plasma TNF-α, HMGB1, MDA, creatinine, and urea levels compared to the CLP+Saline group. Moreover, Tibolone elevated SIRT1 and YAP levels in kidney tissues. Histopathological examination demonstrated a significant decrease in tubular epithelial necrosis, luminal debris, dilatation, hemorrhage, and interstitial inflammation in Tibolone-treated rats. CONCLUSION: This study unveils the protective role of Tibolone against sepsis-induced AKI in rats. The improvements in inflammatory and oxidative biomarkers and histological evidence suggest Tibolone's potential as a therapeutic intervention in sepsis-associated kidney injury. The upregulation of SIRT1 and YAP indicates their involvement in Tibolone's renoprotective mechanisms. Further investigations are warranted to explore Tibolone's translational potential in human sepsis-induced AKI.

Department of Emergency Medicine Faculty of Medicine Izmir Katip Celebi University Izmir Turkey

Department of Pediatrics Faculty of Medicine Cerrahpasa University Istanbul Turkey

Depatment of Physiology Faculty of Medicine Demiroglu Bilim University Istanbul Turkey

See more in PubMed

Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M; Sepsis Definitions Task Force. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016:23;315(8):775-87. doi: 10.1001/jama.2016.0289 PubMed DOI

Gotts JE, Matthay MA. Sepsis: Pathophysiology and clinical management. BMJ 2016;353:i1585. doi:10.1136/bmj.i1585 PubMed DOI

Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest.2016;126(1):23-31. doi:10.1172/JCI82224 PubMed DOI

Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets-an updated view. Mediators Inflamm 2013;2013:165974. doi:10.1155/2013/165974 PubMed DOI

Erdogan A, Erdogan MA, Kara AY, Bora S, Yigitturk G, Erbas O. Effect of fluid resuscitation on acute lung injury in a rat model of sepsis. Bratisl Lek Listy 2021;122(4):280-6. doi: 10.4149/BLL_2021_047 PubMed DOI

Cossart YE. The rise and fall of infectious diseases: Australian perspectives, 1914-2014. Med J Aust 2014;201(1 Suppl):S11-S14. doi:10.5694/mja14.00112 PubMed DOI

Nedeva C, Menassa J, Puthalakath H. Sepsis: Inflammation Is a Necessary Evil. Front Cell Dev Biol 2019;7:108. doi:10.3389/fcell.2019.00108 PubMed DOI

Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol 2011;22(6):999-1006. doi:10.1681/ASN.2010050484 PubMed DOI

Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence 2014;5(1):36-44. doi:10.4161/viru.25436 PubMed DOI

Cepinskas G, Wilson J. Inflammatory response in microvascular endothelium in sepsis: role of oxidants. J Clin Biochem Nutr 2008;42(3):175-84. doi: 10.3164/jcbn.2008026 PubMed DOI

Oliveira FRMB, Assreuy J, Sordi R. The role of nitric oxide in sepsis-associated kidney injury. Biosci Rep 2022;42(7):BSR20220093. doi: 10.1042/BSR20220093 PubMed DOI

Lopes-Pires M, Frade-Guanaes JO, Quinlan GJ. Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention. Antioxidants (Basel) 2021;11(1):88. doi: 10.3390/antiox11010088 PubMed DOI

Kloosterboer HJ. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001;76(1-5):231-8. doi:10.1016/s0960-0760(01)00044-9 PubMed DOI

González-Giraldo Y, Forero DA, Echeverria V, Garcia-Segura LM, Barreto GE. Tibolone attenuates inflammatory response by palmitic acid and preserves mitochondrial membrane potential in astrocytic cells through estrogen receptor beta. Mol Cell Endocrinol 2019;486:65-78. doi:10.1016/j.mce.2019.02.017 PubMed DOI

Rymer JM. The effects of Tibolone. Gynecol Endocrinol 1998;12(3):213-20. doi:10.3109/09513599809015548 PubMed DOI

Rymer J, Chapman MG, Fogelman I. Effect of Tibolone on postmenopausal bone loss. Osteoporos Int 1994;4(6):314-9. doi:10.1007/BF01622189 PubMed DOI

Kulkarni J, Gavrilidis E, Wang W, Worsley R, Fitzgerald PB, Gurvich C, Van Rheenen T, Berk M, Burger H. Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age. Mol Psychiatry 2015;20(6):695-702. doi: 10.1038/mp.2014.33 PubMed DOI

Wang X, Buechler NL, Woodruff AG, Long DL, Zabalawi M, Yoza BK, McCall CE, Vachharajani V. Sirtuins and Immuno-Metabolism of Sepsis. Int J Mol Sci 2018;19(9):2738. doi: 10.3390/ijms19092738 PubMed DOI

Gao R, Ma Z, Hu Y, Chen J, Shetty S, Fu J. SIRT1 restrains lung inflammasome activation in a murine model of sepsis. Am J Physiol Lung Cell Mol Physiol 2015;308(8):L847-L853. doi:10.1152/ajplung.00274.2014 PubMed DOI

Gao Q, Zhu H. The Overexpression of Sirtuin1 (SIRT1) Alleviated Lipopolysaccharide (LPS)-Induced Acute Kidney Injury (AKI) via Inhibiting the Activation of Nucleotide-Binding Oligomerization Domain-Like Receptors (NLR) Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Med Sci Monit 2019;25:2718-26. doi:10.12659/MSM.913146 PubMed DOI

Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB, D'Agati V, McNeill H, Campbell KN. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure. J Am Soc Nephrol 2016;27(1):216-26. doi: 10.1681/ASN.2014090916 PubMed DOI

Zhang J, Xu Q, Ren F, Liu Y, Cai R, Yao Y, Zhou MS. Inhibition of YAP activation attenuates renal injury and fibrosis in angiotensin II hypertensive mice. Can J Physiol Pharmacol 2021;99(10):1000-6. doi: 10.1139/cjpp-2021-0033 PubMed DOI

Erbaş O, Taşkiran D. Sepsis-induced changes in behavioral stereotypy in rats; involvement of tumor necrosis factor-alpha, oxidative stress, and dopamine turnover. J Surg Res 2014;186(1):262-8. doi:10.1016/j.jss.2013.08.001 PubMed DOI

Chen JK, Chen J, Thomas G, Kozma SC, Harris RC. S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 2009;297(3):F585-93. doi: 10.1152/ajprenal.00186.2009 PubMed DOI

Chen J, Chen JK, Conway EM, Harris RC. Survivin mediates renal proximal tubule recovery from AKI. J Am Soc Nephrol. 2013 Dec;24(12):2023-33. doi: 10.1681/ASN.2013010076 PubMed DOI

Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54. doi:10.1006/abio.1976.9999 PubMed DOI

Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294(7):813-8. doi: 10.1001/jama.294.7.813 PubMed DOI

Shum HP, Chan KC, Kwan MC, Yeung AW, Cheung EW, Yan WW. Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury. Ther Apher Dial 2013;17(3):305-10. doi:10.1111/j.1744-9987.2012.01147.x PubMed DOI

Başol N, Erbaş O, Çavuşoğlu T, Meral A, Ateş U. Beneficial effects of agomelatine in experimental model of sepsis-related acute kidney injury. Ulus Travma Acil Cerrahi Derg 2016;22(2):121-6. doi:10.5505/tjtes.2015.29499 PubMed DOI

de Medeiros AR, Lamas AZ, Caliman IF, Dalpiaz PL, Firmes LB, de Abreu GR, Moysés MR, Lemos EM, dos Reis AM, Bissoli NS. Tibolone has anti-inflammatory effects in estrogen-deficient female rats on the natriuretic peptide system and TNF-alpha. Regul Pept 2012;179(1-3):55-60. doi: 10.1016/j.regpep.2012.08.015 PubMed DOI

Rezan Karaali, Ejder Saylav Bora, Hüseyin Acar, Yiğit Uyanikgil, Ibrahim Halil Sever, Mumin Alper Erdogan and Oytun Erbaş, 2023. Exploring Beta Blockers' Efficacy in Sepsis-Induced Acute Lung Injury and HMGB1-sRAGE Interaction. Int J Pharmacol. 2023;19:296-304. doi: 10.3923/ijp.2023.296.304 DOI

Wang H, Zhu S, Zhou R, Li W, Sama AE. Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med 2008;10:e32. doi: 10.1017/S1462399408000884 PubMed DOI

Zhao F, Fang Y, Deng S, Li X, Zhou Y, Gong Y, Zhu H, Wang W. Glycyrrhizin Protects Rats from Sepsis by Blocking HMGB1 Signaling. Biomed Res Int 2017;2017:9719647. doi: 10.1155/2017/9719647 PubMed DOI

Fan H, Yang HC, You L, Wang YY, He WJ, Hao CM. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury. Kidney Int 2013;83(3):404-13. doi:10.1038/ki.2012.394 PubMed DOI

Elangovan S, Ramachandran S, Venkatesan N, Ananth S, Gnana-Prakasam JP, Martin PM, Browning DD, Schoenlein PV, Prasad PD, Ganapathy V, Thangaraju M. SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer. Cancer Res 2011;71(21):6654-64. doi: 10.1158/0008-5472.CAN-11-1446 PubMed DOI

Hasegawa K, Wakino S, Simic P, Sakamaki Y, Minakuchi H, Fujimura K, Hosoya K, Komatsu M, Kaneko Y, Kanda T, Kubota E, Tokuyama H, Hayashi K, Guarente L, Itoh H. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med 2013;19(11):1496-504. doi: 10.1038/nm.3363 PubMed DOI

Cheng X, Zhang S, Wen Y, Shi Z. Clinical significance of sirtuin 1 level in sepsis: correlation with disease risk, severity, and mortality risk. Braz J Med Biol Res 2020;54(2):e10271. doi: 10.1590/1414-431X202010271 PubMed DOI

Yi L, Huang X, Guo F, Zhou Z, Chang M, Tang J, Huan J. Lipopolysaccharide Induces Human Pulmonary Micro-Vascular Endothelial Apoptosis via the YAP Signaling Pathway. Front Cell Infect Microbiol 2016;6:133. doi: 10.3389/fcimb.2016.00133 PubMed DOI

Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB, D'Agati V, McNeill H, Campbell KN. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure. J Am Soc Nephrol 2016;27(1):216-26. doi: 10.1681/ASN.2014090916 PubMed DOI

Chen J, You H, Li Y, Xu Y, He Q, Harris RC. EGF Receptor-Dependent YAP Activation Is Important for Renal Recovery from AKI. J Am Soc Nephrol 2018;29(9):2372-85. doi:10.1681/ASN.2017121272 PubMed DOI

Zheng Z, Li C, Shao G, Li J, Xu K, Zhao Z, Zhang Z, Liu J, Wu H. Hippo-YAP/MCP-1 mediated tubular maladaptive repair promote inflammation in renal failed recovery after ischemic AKI. Cell Death Dis 2021;12(8):754. doi: 10.1038/s41419-021-04041-8 PubMed DOI

Aslan A, van den Heuvel MC, Stegeman CA, Popa ER, Leliveld AM, Molema G, Zijlstra JG, Moser J, van Meurs M. Kidney histopathology in lethal human sepsis. Crit Care 2018;22(1):359. doi: 10.1186/s13054-018-2287-3 PubMed DOI

Segura-Uribe JJ, García-de la Torre P, Castillo-Mendieta T, Bribiesca-Cruz I, Orozco-Suárez S, Soriano-Ursúa MA, Pinto-Almazán R, Fuentes-Venado CE, Guerra-Araiza C. Tibolone Improves Memory and Decreases the Content of Amyloid-β Peptides and Tau Protein in the Hippocampus of a Murine Model of Alzheimer's Disease. J Alzheimers Dis 2022;90(4):1437-47. doi: 10.3233/JAD-220434 PubMed DOI

Yin X, Yin Y, Cao FL, Chen YF, Peng Y, Hou WG, Sun SK, Luo ZJ. Tanshinone IIA attenuates the inflammatory response and apoptosis after traumatic injury of the spinal cord in adult rats. PLoS One 2012;7(6):e38381. doi: 10.1371/journal.pone.0038381 PubMed DOI

Kulkarni J, Gavrilidis E, Thomas N, Hudaib AR, Worsley R, Thew C, Bleeker C, Gurvich C. Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone. J Affect Disord 2018;236:88-92. doi: 10.1016/j.jad.2018.04.103 PubMed DOI

Campisi R, Marengo FD. Cardiovascular effects of Tibolone: a selective tissue estrogenic activity regulator. Cardiovasc Drug Rev 2007;25(2):132-45. doi:10.1111/j.1527-3466.2007.00007.x PubMed DOI

Hidalgo-Lanussa O, Ávila-Rodriguez M, Baez-Jurado E, Zamudio J, Echeverria V, Garcia-Segura LM, Barreto GE. Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta. Mol Neurobiol 2018;55(7):5462-77. doi: 10.1007/s12035-017-0777-y PubMed DOI